Table 1.
Compound | Starting Population | Screening Readout | Biological Process Affected | Mechanism of Action | References |
---|---|---|---|---|---|
Cellular Reprogramming | |||||
Reversine | C2C12 cells | alkaline phosphatase as an osteoblast marker | reprogramming from lineage-committed myoblasts to multipotent stage | a dual inhibitor of MEK1 and nonmuscle myosin II heavy chain | Chen et al. (2004) |
BIX-01294 | Oct4, Klf4-transduced mouse embryonic fibroblasts (MEFs) | ESC colony and staining with alkaline phosphatase as a pluripotency marker | reprogramming of Oct4/Klf4-transduced mouse embryonic fibroblasts | a potential G9a histone methyltransferase inhibitor | Shi et al. (2008) |
BayK8644 | a potential L-channel calcium agonist | ||||
Valproic acid | Oct4-, Sox2-, Klf4-, and c-Myc-transduced MEFs | the percentage of Oct4-GFP+ cells | improve reprogramming efficiency of mouse and human fibroblasts | a potential histone deacetylase inhibitor | Huangfu et al., 2008a, Huangfu et al., 2008b |
Kenpaullone | Oct4-, Sox2-, and c-Myc-transduced MEFs | Nanog-Luc activity | induce reprogramming in the absence of Klf4 | a potential GSK-3β inhibitor | Lyssiotis et al. (2009) |
RepSox | Oct4-, Klf4-, and c-Myc-transduced MEFs | the number of Oct4-GFP + colonies | induce reprogramming in the absence of Sox2 | inhibit TGF-β signaling | Ichida et al. (2009) |
Forskolin | Sox2-, Klf4-, and c-Myc-transduced MEFs | the number of Oct4-GFP + colonies | induce reprogramming in the absence of Oct4 | a potential cAMP activator | Hou et al. (2013) |
(S)-(+)-Dimethindene maleate | primed H9 hESCs |
activate the OCT4 distal enhancer |
support the conversion and maintenance of dome-shaped hPSCs from primed hPSCs |
a potential M2 muscarinic receptor antagonist |
Yang et al. (2017) |
minocycline hydrochloride | a potential metalloproteinase inhibitor | ||||
Directed Differentiation | |||||
PD407824 | C2C12 cells | Id2-Luc reporter | synergize with BMP4 to direct hPSC differentiation toward mesoderm or cytotrophoblast stem cells | inhibit checkpoint kinase 1 | Feng et al. (2016) |
Atauprimide | mESCs | immunostaining using SOX17 antibody | prime mouse and human ESC differentiation | interact with NME2 and inhibit nuclear localization | Zhu et al. (2009) |
IDE1 | mESC | Sox17 promoter-driven tdTomato | induce nearly 80% of ESCs to form definitive endoderm | activate TGF-β signaling | Borowiak et al. (2009) |
IDE2 | |||||
Indolactam V | hESC-derived endodermal cells | immunostaining using PDX1 antibody | induce differentiation toward pancreatic progenitors | activate PKC | Chen et al. (2009) |
H1152 | hESC-derived pancreatic progenitors | immunostaining using insulin antibody | increase the generation of insulin-secreting cells | inhibit ROCKII | Ghazizadeh et al. (2017) |
CI-994 | hPSC-derived immature hepatocytes | albumin-Venus reporter | promote hPSC differentiation toward hepatocyte-like cells | inhibit histone deacetylase | Li et al. (2018) |
SU5402 CHIR99021 DAPT |
hPSC-derived neuroectoderm | immunostaining using PAX6 and β3-tubulin antibodies | promote hPSC differentiation toward neurons | a potential VEGFR inhibitor | Chambers et al. (2012) |
a potential GSK-3β inhibitor | |||||
a potential Notch inhibitor | |||||
Selamectin | mESC | immunostaining using tyrosine hydroxylase antibody | transform mPSCs into neurons | a potential GABAA agonist | Sun et al. (2013) |
Phenanthroline | hESC-derived lens placode | SIX1 H2B::GFP reporter | promote differentiation from nonneural ectoderm to cranial placode | a potential metalloprotease inhibitor | Tchieu et al. (2017) |
KY02111 | monkey ESCs | αMHC promoter-driven EGFP | PSC differentiation toward cardiomyocytes | NA | Minami et al. (2012) |
Sodium nitroprusside | mESC-derived mesodermal cells | CCS:lacz reporter | promote the generation of cardiac Purkinje fiber-like cells | increase intracellular cAMP | Tsai et al. (2015) |
Stem Cell-Based Disease Models | |||||
SKF-86466 | wild-type and familial dysautonomia iPSC-derived neural crest cells | alamarBlue to detect cell survival qRT-PCR to detect IKBKAP expression |
rescue IKAP protein expression and the disease-specific loss of autonomic neuronal marker expression | a potential α2-adrenoceptor antagonist | Lee et al. (2012) |
Kenpaullone | wild-type and SOD1G93A HB9::GFP mESC-derived motor neuron | imaging-based assay to count GFP+ cell number | prolong the healthy survival both mouse and human motor neurons | a potential dual inhibitor of GSK-3 and HGK kinases | Yang et al. (2013) |
Alsterpaullone | fibroblasts from parental SMA carriers | immunostaining using SMN antibody | increase cellular SMN | a potential GSK-3 inhibitor | Makhortova et al. (2011) |
E34 | a co-culture of mESC-derived motor neurons, astrocytes, and interferon-γ- and lipopolysaccharide-activated microglial cells | the total neurite length of all neurites of the motor neurons | prevent the neurons from cytokine and lipopolysaccharide-induced degeneration | inhibit nitric oxide synthase | Hoing et al. (2012) |
Pepstatin A | EDNRB-null mutant hESC-derived enteric nervous system precursors | cell migration assay | rescue loss of EDNRB-induced cell migration defects | inhibit BACE2 | Fattahi et al. (2016) |
Avermectins | TS21 iPSC-derived cortical neurons | the activity of lactate dehydrogenase in medium | increase the relative production of short Aβ peptides at the expense of longer, potentially more toxic peptides | NA | Brownjohn et al. (2017) |
Gardiac glycosides | familial hypercholesterolemia iPSC-derived hepatocyte-like cells | ELISA-based assay to detect apolipoprotein B (apoB) production | reduce the production of apoB | potential inhibitors of the membrane sodium-potassium (NA+-K+) pump | Cayo et al. (2017) |
T5524 | CDKAL1−/− hESC-derived pancreatic β-like cells | staining with PI and insulin antibody | rescues loss of CDKAL1 induced increased sensitivity to glucolipotoxcity | inhibit the FOS/JUN pathway | Zeng et al. (2016) |
Galunisertib | GLIS3−/− hESC-derived pancreatic β-like cells | staining with PI and insulin antibody | rescues loss of CDKAL1 induced pancreatic β cell death | inhibit TGF-β pathway | Amin et al. (2018) |
Emricasan | hNPCs | caspase-3/7 activity assay | block ZIKV-induced hNPC death | a pan-caspase inhibitor | Xu et al. (2016) |
Niclosamide | inhibits ZIKV replication | NA | |||
Hippeastrine hydrobromide | hNPCs | staining with ZIKV antibody | eliminate ZIKV infection | NA | Zhou et al. (2017) |
Geneticin | familial adenomatous polyposis-iPSC-derived colonic organoids | staining with CDX2 and Ki67 antibodies | rescue early stop codon caused APC protein decrease and increased cell proliferation | NA | Crespo et al. (2017) |
NA, not applicable.